A new viral-looking study is fueling optimism in Parkinson’s research by spotlighting a surprising candidate: prasugrel, an antiplatelet drug best known for preventing blood clots. Researchers report that repurposing prasugrel may deliver neuroprotective benefits, pairing biological evidence with large-scale protein profiling to suggest why the drug could matter in degenerating brain circuits. The work examines […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.